Organization · Venture Capital
Pier 70 Ventures
Pier 70 Ventures is a Seattle-based venture capital firm focused on early-stage healthcare innovation, emphasizing diverse leadership teams and impact-driven technologies. The firm operates additional offices in Indianapolis, New York, and San Francisco.
Overview
What Pier 70 Ventures does
What Pier 70 Ventures is
Pier 70 Ventures is a Seattle-based venture capital firm focused on early-stage healthcare innovation, emphasizing diverse leadership teams and impact-driven technologies. The firm operates additional offices in Indianapolis, New York, and San Francisco.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Pier 70 Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pier 70 Ventures as a funder
Investment thesis
Pier 70 Ventures focuses on early-stage healthcare innovation, emphasizing diverse leadership teams as a driver of superior financial returns.
Focus narrative
The firm invests in impact-driven innovation, specifically targeting early-stage companies that are shaping the future of health. Their investment strategy emphasizes diverse teams and technologies that are patient-centric, wellness-focused, data-driven, connected, cloud-based, and AI-enabled. Pier 70 Ventures seeks to generate financial returns while contributing to societal change and economic benefits.
Value beyond capital
Pier 70 Ventures adds value to its portfolio companies through mentorship, strategic guidance, and access to a global network of industry experts and resources, fostering innovation and growth in the healthcare sector.
Terms and economics
- Typical check
- $250,000–$2,000,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 16
Portfolio context
Notable portfolio companies include: Adipo Therapeutics (innovative therapies), Antigenix Therapeutics (therapeutic development), Amplified Sciences (advanced scientific solutions), DermaSensor (technology for skin health), Movn Health (enhancing health outcomes through technology), and Nestle Performance (performance nutrition).
Common questions
What to know about Pier 70 Ventures
Upseed classifies Pier 70 Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.